Publications by authors named "Julie Ritchey"

Claim this Profile
T
Targeting CD117 on hematopoietic stem and progenitor cells impairs CAR T cell activity.
Rubina Thomas, Julie K Ritchey, John F DiPersio, Miriam Y Kim

Mol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation.
Ramzi Abboud, Mark A Schroeder, Michael P Rettig, Reyka G Jayasinghe, Feng Gao, Julie Ritchey

Blood· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of non-Hodgkin lymphoma with point-of-care manufactured CAR T cells: a dual institution, phase 1 trial.
Armin Ghobadi, Paolo F Caimi, Jane S Reese, Krishna Goparaju, Martina di Trani, Julie Ritchey

EClinicalMedicine· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors.
Ju-Fang Chang, Jack H Landmann, Tien-Ching Chang, Mehmet Emrah Selli, Yangdon Tenzin, Julie Ritchey

Cancer Discov· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies.
Matthew J Frigault, Charlotte E Graham, Trisha R Berger, Julie Ritchey, Nora K Horick

Blood· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conditioning with anti-CD47 and anti-CD117 plus JAK inhibition enables toxic payload-free allogeneic transplantation.
Stephen P Persaud, Aditya R Yelamali, Julie K Ritchey, John F DiPersio

Blood Adv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control of acute myeloid leukemia and generation of immune memory in vivo using AMV564, a bivalent bispecific CD33 x CD3 T cell engager.
Linda G Eissenberg, Julie K Ritchey, Michael P Rettig, Dilan A Patel, Kiran Vij

PLoS One· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel JAK Inhibitors to Reduce Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in a Preclinical Mouse Model.
Sena Kim, Peter Ruminski, Megh Singh, Karl Staser, Kidist Ashami, Julie Ritchey

Molecules· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization.
Daniel Cancilla, Michael P Rettig, Darja Karpova, Haresh Thakellapalli, Megh Singh, Julie K Ritchey

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinatumomab consolidation post-autologous stem cell transplantation in patients with diffuse large B-cell lymphoma.
Armin Ghobadi, Nicole C Foley, Jared Cohen, Michael P Rettig, Amanda F Cashen, Julie Ritchey

Blood Adv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Streptavidin-drug conjugates streamline optimization of antibody-based conditioning for hematopoietic stem cell transplantation.
Aditya R Yelamali, Ezhilarasi Chendamarai, Julie K Ritchey, Michael P Rettig, John F DiPersio

bioRxiv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignancies.
Jingyu Xiang, Jessica M Devenport, Alun J Carter, Karl W Staser, Miriam Y Kim, Julie K Ritchey

Leukemia· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duvelisib for Critically Ill Patients With Coronavirus Disease 2019: An Investigator-Initiated, Randomized, Placebo-Controlled, Double-Blind Pilot Trial.
Scott R Goldsmith, Fahrettin Covut, Mark Fiala, Zhifu Xiang, Zahid Iqbal, Julie Ritchey

Open Forum Infect Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc.
Julie O'Neal, Matthew L Cooper, Julie K Ritchey, Susan Gladney, Jessica Niswonger

Blood Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models.
Ramzi Abboud, Sena Kim, Karl Staser, Reyka G Jayasinghe, Sora Lim, Julie Ritchey

Front Immunol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flotetuzumab and other T-cell immunotherapies upregulate MHC class II expression on acute myeloid leukemia cells.
Joseph C Rimando, Ezhilarasi Chendamarai, Michael P Rettig, Reyka Jayasinghe, Matthew J Christopher, Julie K Ritchey

Blood· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S100A9 upregulated by IFNGR signaling blockade functions as a novel GVHD suppressor without compromising GVL in mice.
Sena Kim, Sora Lim, Boram Kim, Julie Ritchey, Kiran Vij

Blood· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells.
Julie O'Neal, Julie K Ritchey, Matthew L Cooper, Jessica Niswonger, L Sofía González

Leukemia· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity.
Miriam Y Kim, Reyka Jayasinghe, Jessica M Devenport, Julie K Ritchey, Michael P Rettig

Nat Commun· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liposomal phytohemagglutinin: In vivo T-cell activator as a novel pan-cancer immunotherapy.
Kinan Alhallak, Jennifer Sun, Barbara Muz, Amanda Jeske, Julie O'Neal, Julie K Ritchey

J Cell Mol Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baricitinib prevents GvHD by increasing Tregs via JAK3 and treats established GvHD by promoting intestinal tissue repair via EGFR.
Sena Kim, Kidist Ashami, Sora Lim, Karl Staser, Kiran Vij, Julie Ritchey

Leukemia· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival.
Deep Hathi, Chantiya Chanswangphuwana, Nicholas Cho, Francesca Fontana, Dolonchampa Maji, Julie Ritchey

Sci Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-drug conjugates plus Janus kinase inhibitors enable MHC-mismatched allogeneic hematopoietic stem cell transplantation.
Stephen P Persaud, Julie K Ritchey, Sena Kim, Sora Lim, Peter G Ruminski

J Clin Invest· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy.
Miriam Y Kim, Matthew L Cooper, Miriam T Jacobs, Julie K Ritchey, Julia Hollaway

JCI Insight· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes.
Eric Huselton, Michael P Rettig, Theresa Fletcher, Julie Ritchey, Leah Gehrs

Leuk Lymphoma· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis